BACK (IMAC Holdings) Earnings Yield (Joel Greenblatt) %: -212.77% (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is IMAC Holdings Earnings Yield (Joel Greenblatt) %?

IMAC Holdings BACK -0.48% Earnings Yield (Joel Greenblatt) % is -212.77% as of Sep. 2025. The stock has 7 warning signs investors should review. Among 689 Healthcare Providers & Services companies, IMAC Holdings ranks worse than 98.26% on this metric.

IMAC Holdings's Enterprise Value for the quarter that ended in Sep. 2025 was $4.05 Mil. IMAC Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was $-8.58 Mil. IMAC Holdings's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2025 was -212.77%.

The historical rank and industry rank for IMAC Holdings's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

BACK' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -1540.4   Med: -69.62   Max: 1411.22
Current: -222.22

During the past 9 years, the highest Earnings Yield (Joel Greenblatt) of IMAC Holdings was 1411.22%. The lowest was -1540.40%. And the median was -69.62%.

BACK's Earnings Yield (Joel Greenblatt) % is ranked worse than
98.26% of 689 companies
in the Healthcare Providers & Services industry
Industry Median: 3.31 vs BACK: -222.22

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. IMAC Holdings's Forward Rate of Return (Yacktman) % for the quarter that ended in Sep. 2025 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


IMAC Holdings  (OTCPK:BACK) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


IMAC Holdings Earnings Yield (Joel Greenblatt) % Related Terms


IMAC Holdings Earnings Yield (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for IMAC Holdings's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMAC Holdings Earnings Yield (Joel Greenblatt) % Chart

IMAC Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only -19.12 -34.97 -204.08 -277.78 -270.27

IMAC Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -125.00 -270.27 -1,000.00 -384.62 -212.77

BACK vs FCHS, NHLG, PAIYY: Earnings Yield (Joel Greenblatt) % Comparison

For the Medical Care Facilities subindustry, IMAC Holdings's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMAC Holdings Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, IMAC Holdings's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where IMAC Holdings's Earnings Yield (Joel Greenblatt) % falls into.



IMAC Holdings Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

IMAC Holdingss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2024 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-5.62/2.0741
=-270.96 %

IMAC Holdings's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.58 Mil.


What does a Earnings Yield (Joel Greenblatt) % of -212.77% mean?
IMAC Holdings (BACK) has a Earnings Yield (Joel Greenblatt) % of -212.77% as of Sep. 2025. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on IMAC Holdings and its competitors. According to the industry distribution chart, IMAC Holdings ranks #677 out of 689 companies in the Healthcare Providers & Services industry, placing it in the top 98.3%.
Is IMAC Holdings' Earnings Yield (Joel Greenblatt) % too high?
IMAC Holdings' current Earnings Yield (Joel Greenblatt) % is -212.77%. Based on the distribution chart, IMAC Holdings ranks #677 out of 689 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does IMAC Holdings' Earnings Yield (Joel Greenblatt) % compare to FCHS and NHLG?
According to the Healthcare Providers & Services industry distribution chart, IMAC Holdings ranks #677 out of 689 companies for Earnings Yield (Joel Greenblatt) %. This places IMAC Holdings in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.31, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on IMAC Holdings and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMAC Holdings's current Earnings Yield (Joel Greenblatt) % is -212.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMAC Holdings stock overvalued right now?
IMAC Holdings (BACK) has a current Earnings Yield (Joel Greenblatt) % of -212.77%. The current Earnings Yield (Joel Greenblatt) % is -212.77%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For IMAC Holdings (BACK), the current Earnings Yield (Joel Greenblatt) % is -212.77% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMAC Holdings Business Description

Address 3401 Mallory Lane, Suite 100, Franklin, TN, USA, 37067
IMAC Holdings Inc is engaged in providing services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, located in a single geographic location, the United States.